HK1252207A1 - 一種組合物在製備治療肌萎縮性側索硬化症藥物中的應用 - Google Patents
一種組合物在製備治療肌萎縮性側索硬化症藥物中的應用Info
- Publication number
- HK1252207A1 HK1252207A1 HK18111444.9A HK18111444A HK1252207A1 HK 1252207 A1 HK1252207 A1 HK 1252207A1 HK 18111444 A HK18111444 A HK 18111444A HK 1252207 A1 HK1252207 A1 HK 1252207A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicament
- preparing
- treatment
- composition
- lateral sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510314584 | 2015-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1252207A1 true HK1252207A1 (zh) | 2019-05-24 |
Family
ID=57503062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18111444.9A HK1252207A1 (zh) | 2015-06-10 | 2018-09-06 | 一種組合物在製備治療肌萎縮性側索硬化症藥物中的應用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10206905B2 (zh) |
| EP (1) | EP3308783B1 (zh) |
| JP (1) | JP6450887B2 (zh) |
| CN (2) | CN113559097A (zh) |
| AU (1) | AU2016276488B2 (zh) |
| CA (1) | CA2985219C (zh) |
| ES (1) | ES2877622T3 (zh) |
| HK (1) | HK1252207A1 (zh) |
| WO (1) | WO2016197945A1 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4056573B1 (en) * | 2019-10-30 | 2024-11-06 | PRG S&Tech Inc. | Use of novel compound, for preventing, improving or treating amyotrophic lateral sclerosis |
| CN110801451B (zh) * | 2019-12-16 | 2023-05-26 | 深圳大学 | 一种治疗肌萎缩性脊髓侧索硬化症的药物及提高血脑屏障开放效果的方法 |
| WO2021229466A1 (en) * | 2020-05-12 | 2021-11-18 | Tov «Medychnyi Tsentr «M.T.K.» | Pharmaceutical composition containing edaravone as an active agent |
| EP4176868A1 (en) * | 2020-08-17 | 2023-05-10 | Simcere Pharmaceutical Co., Ltd. | Stable pharmaceutical composition |
| CN114831985B (zh) * | 2021-02-02 | 2024-11-08 | 南京宁丹新药技术有限公司 | 一种含有利鲁唑和冰片组合物在制备治疗脑血管药物中的应用 |
| US12109194B2 (en) | 2021-02-05 | 2024-10-08 | Biojiva Llc | Synergistic combination therapy for treating ALS |
| CN118201611A (zh) | 2021-11-08 | 2024-06-14 | 南京宁丹新药技术有限公司 | 一种含有依达拉奉右莰醇组合物在治疗认知障碍中的应用 |
| WO2023158641A1 (en) * | 2022-02-15 | 2023-08-24 | Retrotope, Inc. | Synergistic combination therapy for treating als |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19513040A1 (de) | 1995-03-29 | 1996-10-02 | Schering Ag | Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| WO2002051395A1 (en) * | 1998-05-28 | 2002-07-04 | Codon Pharmaceuticals, Inc. | Treatment of neurodegenerative diseases |
| ES2248144T3 (es) * | 2000-10-24 | 2006-03-16 | Mitsubishi Pharma Corporation | Medicamentos para tratar la esclerosis lateral amiotrofica (ela). |
| JP3903259B2 (ja) | 2003-09-02 | 2007-04-11 | 北海道セイカン工業株式会社 | 開放型コンテナ |
| EP1714960B1 (en) * | 2004-02-09 | 2018-03-28 | Mitsubishi Tanabe Pharma Corporation | Novel therapeutic agent for amyotrophic lateral sclerosis (als) or disease attributable to als |
| CN101524352A (zh) | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
| JP2013035712A (ja) | 2011-08-08 | 2013-02-21 | Panasonic Corp | シリコン製造方法およびシリコン製造装置 |
| KR20190049905A (ko) | 2011-09-05 | 2019-05-09 | 미쓰비시 타나베 파마 코퍼레이션 | 근위축성 측색경화증의 치료 또는 병세 진전 억제를 위한 약제 |
| CN104546832A (zh) | 2013-10-12 | 2015-04-29 | 烟台益诺依生物医药科技有限公司 | 一种药物组合物在制备治疗脓毒症药物中应用 |
| US20180126014A1 (en) * | 2015-04-15 | 2018-05-10 | Yale University | Compositions for enhancing delivery of agents across the blood brain barrier and methods of use thereof |
-
2016
- 2016-06-08 EP EP16806843.5A patent/EP3308783B1/en active Active
- 2016-06-08 CA CA2985219A patent/CA2985219C/en active Active
- 2016-06-08 CN CN202110874553.XA patent/CN113559097A/zh active Pending
- 2016-06-08 AU AU2016276488A patent/AU2016276488B2/en active Active
- 2016-06-08 JP JP2018512476A patent/JP6450887B2/ja active Active
- 2016-06-08 WO PCT/CN2016/085269 patent/WO2016197945A1/zh active Application Filing
- 2016-06-08 US US15/574,693 patent/US10206905B2/en active Active
- 2016-06-08 CN CN201680029994.7A patent/CN107613976B/zh active Active
- 2016-06-08 ES ES16806843T patent/ES2877622T3/es active Active
-
2018
- 2018-09-06 HK HK18111444.9A patent/HK1252207A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2985219A1 (en) | 2016-12-15 |
| EP3308783A1 (en) | 2018-04-18 |
| EP3308783B1 (en) | 2021-03-03 |
| CN107613976A (zh) | 2018-01-19 |
| US10206905B2 (en) | 2019-02-19 |
| EP3308783A4 (en) | 2019-02-06 |
| CA2985219C (en) | 2020-04-28 |
| AU2016276488B2 (en) | 2019-04-04 |
| WO2016197945A1 (zh) | 2016-12-15 |
| CN107613976B (zh) | 2021-07-06 |
| AU2016276488A1 (en) | 2017-11-30 |
| US20180318261A1 (en) | 2018-11-08 |
| CN113559097A (zh) | 2021-10-29 |
| ES2877622T3 (es) | 2021-11-17 |
| JP6450887B2 (ja) | 2019-01-09 |
| JP2018515621A (ja) | 2018-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290823A (en) | Pharmaceutical preparations for combination therapy | |
| HK1252207A1 (zh) | 一種組合物在製備治療肌萎縮性側索硬化症藥物中的應用 | |
| IL268316B (en) | Pharmaceutical preparations for combined treatment | |
| EP3210604C0 (en) | USES OF A DULOXETINE HCL MEDICATION IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| ZA201705256B (en) | Use of a composition for reducing the drift when applying a plant treatment composition | |
| ZA201901241B (en) | Nasal powder formulation for treatment of hypoglycemia | |
| IL252296B (en) | A pharmaceutical preparation containing dimethyl fumarate for the treatment of multiple sclerosis | |
| IL253461A0 (en) | Hydrogels for the release of therapeutic compounds | |
| PL3348260T3 (pl) | Kompozycja farmaceutyczna tramadolu do zastosowania oftalmicznego | |
| ZA201607729B (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| GB201506526D0 (en) | Medicinal composition | |
| PT3142641T (pt) | Formulações para o tratamento de hipertiroidismo | |
| PL3223799T3 (pl) | Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer | |
| SG11201608123VA (en) | Pharmaceutical composition for external use | |
| PL3164110T3 (pl) | Kompozycje farmaceutyczne do leczenia łuszczycy | |
| SG11201608124XA (en) | Pharmaceutical composition for external use | |
| AU2015901877A0 (en) | Treatment of amyotrophic lateral sclerosis | |
| SG11201708197QA (en) | Pharmaceutical composition for skin | |
| GB201512635D0 (en) | Uses of therapeutic compounds | |
| SG11201608122PA (en) | Pharmaceutical composition for external use | |
| IL236381A0 (en) | Pharmaceutical preparations for the treatment of cancer | |
| PL2812351T3 (pl) | Kompozycja farmaceutyczna do leczenia stwardnienia rozsianego |